Skip to main navigation Skip to search Skip to main content

Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene

  • Kathrin A Schmohl
  • , Aayush Gupta
  • , Geoffrey K Grünwald
  • , Marija Trajkovic-Arsic
  • , Kathrin Klutz
  • , Rickmer Braren
  • , Markus Schwaiger
  • , Peter J Nelson
  • , Manfred Ogris
  • , Ernst Wagner
  • , Jens T Siveke
  • , Christine Spitzweg

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)33393-33404
    Number of pages12
    JournalOncotarget
    Volume8
    Issue number20
    DOIs
    Publication statusPublished - 2017

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry

    Keywords

    • Journal Article
    • CELLS
    • gene therapy
    • EGFR-targeting
    • sodium iodide symporter
    • genetically engineered mouse model
    • pancreatic ductal adenocarcinoma
    • LIVER-CANCER
    • GROWTH-FACTOR RECEPTOR
    • INHIBITION
    • RADIOIODINE THERAPY
    • MOUSE MODEL
    • PROSTATE-CANCER
    • HEPATOCELLULAR CANCER
    • SYSTEMIC NONVIRAL DELIVERY
    • EGF RECEPTOR
    • Genetically engineered mouse model
    • Pancreatic ductal adenocarcinoma
    • Sodium iodide symporter
    • Gene therapy

    Fingerprint

    Dive into the research topics of 'Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene'. Together they form a unique fingerprint.

    Cite this